Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice.

However, the heart mass/body mass ratio was significantly lower in the SFN‐treated group, the Zn‐treated group and the combined treatment group, with the combined treatment group showing a trend towards being even lower than in the other groups, although this difference did not reach statistical significance (Figure 3 A). 3.2.2.

also in 111,027 other papers